| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Credit > The Lowdown on the Citi PremierPass Card |
|
Digg It - The Lowdown on the Citi PremierPass Card
The Citi PremierPass Card combines the traditional points-per-dollar spent system with an airline frequent f According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product lyer program where airline miles are awarded based on distance flown. The result is a unique reward program ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nlike any other. Catering to people with an excellent credit rating, the card is offered in three flavors – lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he Citi PremierPass Card - Elite Level, the Citi PremierPass Card and the CitiBusiness PremierPass Card. Wi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h the Citi PremierPass Card, cardholders are eligible for one Thank You Network Point per dollar spent for a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y and all purchases. Cardholders are also eligible for one point for every mile flown on any airline of thei ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc r choice. Thank You Flight Points are earned as long as the ticket is bought with the card, regardless of wh easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi actually boards the plane. However, if you have purchased a ticket for yourself and your family on the sam nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically flight and utilize your Citi PremierPass Card for payment, only the airline miles for your ticket will be a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ arded. Nonetheless, this reward program is still alluring as points earned can be redeemed for all types of ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ifts through Citi’s Thank You Network. Also, even though Thank You Flight Points are not convertible to airl ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ine miles, they are redeemable for airline tickets, in exchange for points earned through general purchases. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod However, there is a cap set at 100,000 points per year, but the points will not expire as long as cardholde cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s charge at least one purchase every three years to the card in order to keep the account active. Apart from tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen that, this card also offers additional perks such as no annual fees charged and a long 0% introductory rate t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel f 12 months. APR rates are also reasonably low beyond the introductory period, although there is a minimum i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nterest rate incurred for cash advances. In conclusion, the Citi PremierPass Card offers a good balance of y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products dvantages and disadvantages for cardholders. While the perks look pretty attractive, it is the spending habi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s of the cardholder that will drive these benefits or advantages. In the end, even if the perks are attracti elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e, but a bad-spending habit will just get you into snowballing debt no matter how low the interest rates are tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Financing Your Business - Is The Small Business Administration Still A Choice? Profitable Relationships: Is It Amateur Hour or King of the Hill?
|